Cargando…

Fibrinolytic-deficiencies predispose hosts to septicemia from a catheter-associated UTI

Catheter-associated urinary tract infections (CAUTIs) are amongst the most common nosocomial infections worldwide and are difficult to treat due to multi-drug resistance development among the CAUTI-related pathogens. Importantly, CAUTI often leads to secondary bloodstream infections and death. A maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina, Jonathan J., Kohler, Kurt N., Gager, Christopher, Andersen, Marissa J., Wongso, Ellsa, Lucas, Elizabeth R., Paik, Andrew, Xu, Wei, Donahue, Deborah L., Bergeron, Karla, Klim, Aleksandra, Caparon, Michael G., Hultgren, Scott J., Desai, Alana, Ploplis, Victoria A., Flick, Matthew J., Castellino, Francis J., Flores-Mireles, Ana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543281/
https://www.ncbi.nlm.nih.gov/pubmed/37790429
http://dx.doi.org/10.21203/rs.3.rs-3263501/v1
Descripción
Sumario:Catheter-associated urinary tract infections (CAUTIs) are amongst the most common nosocomial infections worldwide and are difficult to treat due to multi-drug resistance development among the CAUTI-related pathogens. Importantly, CAUTI often leads to secondary bloodstream infections and death. A major challenge is to predict when patients will develop CAUTIs and which populations are at-risk for bloodstream infections. Catheter-induced inflammation promotes fibrinogen (Fg) and fibrin accumulation in the bladder which are exploited as a biofilm formation platform by CAUTI pathogens. Using our established mouse model of CAUTI, we identified that host populations exhibiting either genetic or acquired fibrinolytic-deficiencies, inducing fibrin deposition in the catheterized bladder, are predisposed to severe CAUTI and septicemia by diverse uropathogens in mono- and poly-microbial infections. Furthermore, we found that E. faecalis, a prevalent CAUTI pathogen, uses the secreted protease, SprE, to induce fibrin accumulation and create a niche ideal for growth, biofilm formation, and persistence during CAUTI.